Hoppenot Herve

Avg. Two Year Performance

28% Avg. Purchase Return
13% Compound
9% Avg. Sale Return
5% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return5%4%2%16%28%
Purchase Success Rate1 of 21 of 21 of 21 of 21 of 2
Average Sale Return6%17%13%12%9%
Sale Success Rate3 of 33 of 32 of 31 of 31 of 3
Drugs » Biotechnology

Chairman / CEO, Director:

Holdings: 496.67K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--